Andra Ap Fonden Vertex Pharmaceuticals Inc Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

A detailed history of Andra Ap Fonden transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Andra Ap Fonden holds 41,600 shares of VRTX stock, worth $17 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

41,600

Previous 69,800 40.4%

Holding current value

$17 Million

Previous $32.7 Million 40.86%

% of portfolio

0.29%

Previous 0.56%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $13 Million - $14.3 Million	-28,200 Reduced 40.4%	41,600 $19.3 Million
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $4.71 Million - $5.83 Million	-12,000 Reduced 14.67%	69,800 $32.7 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $24 Million - $26.2 Million	58,800 Added 255.65%	81,800 $34.2 Million
Q4 2023 Feb 15, 2024	BUY	$343.0 - $410.68 $1.99 Million - $2.38 Million	5,800 Added 33.72%	23,000 $9.36 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $270,544 - $289,968	-800 Reduced 4.44%	17,200 $5.98 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $5.22 Million - $5.84 Million	-16,600 Reduced 47.98%	18,000 $6.33 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $2.66 Million - $3.04 Million	-9,400 Reduced 21.36%	34,600 $10.9 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $3.71 Million - $4.18 Million	-13,000 Reduced 22.81%	44,000 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $1.67 Million - $1.86 Million	-6,100 Reduced 9.67%	57,000 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $2.94 Million - $3.66 Million	-12,500 Reduced 16.53%	63,100 $17.8 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $725,741 - $916,145	4,100 Added 5.73%	75,600 $16.6 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $489,752 - $548,073	2,700 Added 3.92%	71,500 $13 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $4.22 Million - $4.97 Million	22,500 Added 48.6%	68,800 $13.9 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.04 Million - $1.21 Million	-5,000 Reduced 9.75%	46,300 $9.95 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $4.31 Million - $5.74 Million	20,800 Added 68.2%	51,300 $12.1 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $51,130 - $60,620	200 Added 0.66%	30,500 $8.3 Million
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $1.4 Million - $1.83 Million	6,200 Added 25.73%	30,300 $8.8 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $319,632 - $396,496	1,600 Added 7.11%	24,100 $5.74 Million
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $716,853 - $962,813	4,300 Added 23.63%	22,500 $4.93 Million
Q2 2019 Aug 15, 2019	SELL	$164.61 - $190.37 $1.76 Million - $2.04 Million	-10,700 Reduced 37.02%	18,200 $3.34 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $1.21 Million - $1.44 Million	-7,400 Reduced 20.39%	28,900 $5.32 Million
Q3 2018 Oct 16, 2018	BUY	$167.73 - $192.74 $335,460 - $385,480	2,000 Added 5.83%	36,300 $7 Million
Q2 2018 Aug 17, 2018	SELL	$145.72 - $169.96 $684,884 - $798,812	-4,700 Reduced 12.05%	34,300 $5.83 Million
Q1 2018 Apr 10, 2018	BUY	$151.6 - $177.13 $2.46 Million - $2.87 Million	16,200 Added 71.05%	39,000 $6.36 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $123,552 - $139,995	900 Added 4.11%	22,800 $3.42 Million
Q3 2017 Oct 31, 2017	BUY	$148.13 - $162.24 $3.24 Million - $3.55 Million	21,900	21,900 $3.33 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account